- $4.14bn
- $3.70bn
- $1.00bn
NYSE ORDER IMBALANCE 79032.0 SHARES ON SELL SIDE
NYSE ORDER IMBALANCE 87616.0 SHARES ON SELL SIDE
NYSE ORDER IMBALANCE 55876.0 SHARES ON BUY SIDE
NYSE ORDER IMBALANCE 318418.0 SHARES ON BUY SIDE
NYSE ORDER IMBALANCE 76286.0 SHARES ON BUY SIDE
NYSE ORDER IMBALANCE 59947.0 SHARES ON SELL SIDE
NYSE ORDER IMBALANCE 68005.0 SHARES ON BUY SIDE
NYSE ORDER IMBALANCE 100756.0 SHARES ON BUY SIDE
NYSE ORDER IMBALANCE 53876.0 SHARES ON BUY SIDE
NYSE ORDER IMBALANCE 69266.0 SHARES ON BUY SIDE
NYSE ORDER IMBALANCE 63198.0 SHARES ON BUY SIDE
NYSE ORDER IMBALANCE 77056.0 SHARES ON SELL SIDE
NYSE ORDER IMBALANCE 72346.0 SHARES ON BUY SIDE
NYSE ORDER IMBALANCE 74443.0 SHARES ON SELL SIDE
NYSE ORDER IMBALANCE 64174.0 SHARES ON SELL SIDE
NYSE ORDER IMBALANCE 53367.0 SHARES ON BUY SIDE
NYSE ORDER IMBALANCE 88190.0 SHARES ON SELL SIDE
NYSE ORDER IMBALANCE 54433.0 SHARES ON SELL SIDE
U.S. RESEARCH ROUNDUP- Carvana, McKesson, Nektar Therapeutics